PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinoma.
about
Knockdown of PD-L1 in Human Gastric Cancer Cells Inhibits Tumor Progression and Improves the Cytotoxic Sensitivity to CIK Therapy.STAT3-targeted treatment with silibinin overcomes the acquired resistance to crizotinib in ALK-rearranged lung cancer.Epigenetic regulation of E-cadherin expression by the histone demethylase UTX in colon cancer cells.Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape.Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potential.Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.Type Iγ phosphatidylinositol phosphate kinase regulates PD-L1 expression by activating NF-κB.Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers.The tissue distribution and significance of B7-H4 in laryngeal carcinoma.Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability.Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.Prognostic significance of PD-L1 expression on tumor cells and tumor-infiltrating mononuclear cells in upper tract urothelial carcinoma.ATM‑JAK‑PD‑L1 signaling pathway inhibition decreases EMT and metastasis of androgen‑independent prostate cancer.The Major Role of NF-kB in the Depth of Invasion on Acral Melanoma by Decreasing CD8+ T Cells.Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune EvasionRelationship between epithelial-to-mesenchymal transition and the inflammatory microenvironment of hepatocellular carcinomaThe implications of signaling lipids in cancer metastasis
P2860
Q38715520-7DAEF2DB-47C1-44A8-9DFC-817C79921FF4Q38740295-948635FA-80E5-4B37-83D3-00C87BDDEE32Q38798997-70A248E7-2F62-46CD-8E0D-A36D8AC2EEA1Q38958563-0250A8F5-9A58-416D-8A3F-659FF88E3BADQ39395931-13D12064-74D1-4391-91C8-029B0F352E33Q40498385-0AAE2139-470B-4CBD-BB08-EBA48F085AFDQ41964740-C1249140-7B1C-46CC-8E40-52B5F138EA50Q42275171-9A2A9C03-91DD-4D5A-A687-69C4AC1C0935Q47102186-2AE123A8-C932-4B39-A56C-703EF1306294Q47634752-CF34DD49-A39D-423B-BDB9-039ED6CBB74EQ48182109-8CCDCDB7-392A-4C46-B900-DB1E16F59FA4Q51058859-2EF6AB4A-3639-4498-9058-F4FA4A0F0618Q52641296-8196400A-E36F-4B53-9E20-AA2A5EF88F2FQ53406743-35373C5D-8F0F-448A-A7C4-24201CED19DCQ57072897-B7AB9857-1000-411C-B4AD-5F33E9ED853EQ58696594-C0CEE458-1064-4632-A2CE-CA64F1DC1AC5Q58705856-ED6ADB08-771C-4C98-9F9A-D2365536EDE1
P2860
PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
PD-L1 induces epithelial-to-me ...... BP-1c in renal cell carcinoma.
@en
type
label
PD-L1 induces epithelial-to-me ...... BP-1c in renal cell carcinoma.
@en
prefLabel
PD-L1 induces epithelial-to-me ...... BP-1c in renal cell carcinoma.
@en
P2093
P2860
P1433
P1476
PD-L1 induces epithelial-to-me ...... BP-1c in renal cell carcinoma.
@en
P2093
P2860
P2888
P356
10.1007/S12032-015-0655-2
P577
2015-07-04T00:00:00Z
P6179
1007960730